Paper Review — verify claims with raw data
Extract figures, tables, methods, and underlying data to audit results.
Press Enter ↵ to review
| Evidence tier | What to demonstrate | Where the provided studies give support | Main remaining uncertainty (from excerpts) |
|---|---|---|---|
| Purity / subtypes | Marker-based fractionation that yields reproducible distinct EV populations | TET8 vs PEN1 label distinct populations; protease-protection used to support packaging | Transient expression artifacts; stable-line validation needed |
| Cargo composition | Proteomics and/or RNA-seq from EV fractions (with controls) | Apoplast EV proteomics shows stress/defense enrichment; EV secretion increases during infection | Functional roles of identified proteins require further in vivo confirmation; EV uptake remains unclear |
| Delivery | Recipient-cell evidence (subcellular localization / reporter reconstitution) | VirE2 delivered to plant cytosol via EVs (split-GFP-like evidence) | The excerpt states nucleic acid cargo wasn’t analyzed; mechanistic dissection of which EV components drive phenotypes is limited |
| Function | Phenotype changes tied to specific EV subtype/cargo (preferably with perturbations) | OMVs induce plant immune readouts; EV-mediated delivery/phenotypes in microbial–plant interactions are described (e.g., tumor assays) and | Generalization across pathogens/hosts remains uncertain; some functional roles are not directly tied to purified single cargo species |
New scientific claims, supporting evidence, and important limitations. Every Friday. No ads.